REGistry of Long-term AnTithrombotic TherApy-2 (REGATTA-2)

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Status: Enrolling

Conditions: Atrial Fibrillation

Treatments: Drug: Anticoagulants

Study type: Observational

Funder types: Other

Identifiers

NCT04347187

REGATTA203121975

Details and patient eligibility

About

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation

Full description

The register is a Russian prospective single-center observational study of patients who have indications for long-term antithrombotic therapy in connection with atrial fibrillation

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Documented atrial fibrillation with CHA2DS2VASC > 1

Exclusion criteria

• Subjects who are unwilling or unable to provide informed consent. ACS within 12 months before inclusion Severe CHF (NYHA IV) Stroke within 6 months before inclusion Severe liver or muscle disease Severe kidney disease / renal failure with creatinine > 3 mg/dl Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention